Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

China Immunotech (beijing) Biotechnology Co., Ltd.

Clinical trials sponsored by China Immunotech (beijing) Biotechnology Co., Ltd., explained in plain language.

Trials to join now! 4 Not yet recruiting 1 Completed 1

Experimental cell therapy offers hope for Tough-to-Treat blood disorder

Disease control Not yet recruiting

This early-stage study is testing a new cell therapy called YTS109 for people with severe autoimmune hemolytic anemia who haven't responded to at least three previous treatments. Researchers will give patients modified immune cells and carefully monitor safety, side effects, and …

Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC